TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33583066

Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.025 ug/kg/min (NE25)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.05 ug/kg/min (NE50)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.075 ug/kg/min (NE75)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.1 ug/kg/min (NE100)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Norepinephrine (all doses)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Norepinephrine and NS
Number of subjects: 99
Study: 32671996

Group type: EXPERIMENTAL
Intervention: PROACTIVE intervention (psycho-educational support)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 13
Study: 34314831

Group type: EXPERIMENTAL
Intervention: Isometric hand exercise training (ISM) at 30% maximum voluntary contraction (MVC) for 10 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isotonic hand exercise training (IST) at 30% maximum voluntary contraction (MVC) for 10 weeks
Number of subjects: 50
Study: 34099186

Group type: EXPERIMENTAL
Intervention: THC (15 mg, oral)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 35325622

Group type: EXPERIMENTAL
Intervention: Aldafermin 0.3 mg
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Aldafermin 1.0 mg
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Aldafermin 3.0 mg
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 32898998

Group type: EXPERIMENTAL
Intervention: Rational Emotive Occupational Health Coaching (REOHC), 2-hour sessions weekly for 12 weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Waitlist group (WLG)
Number of subjects: 87
Study: 35142814

Group type: EXPERIMENTAL
Intervention: Symptom monitoring intervention (daily symptom reports displayed during oncology rounds)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Symptom monitoring intervention
Number of subjects: 321

Group type: COMPARATOR
Intervention: Usual care (symptom reports not displayed)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 321
Study: 34413633

Group type: EXPERIMENTAL
Intervention: Oxycodone 0.25 mg/h (low-dose group)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Oxycodone 0.5 mg/h (control group)
Number of subjects: 140
Study: 32141306

Group type: EXPERIMENTAL
Intervention: Galvanic current electrotherapy with conservative treatment (anti-inflammatory, vasodilatory and analgesic drugs) for 7 weeks, 3 times/week (20 sessions total)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Galvanic current electrotherapy with conservative treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conservative treatment (anti-inflammatory, vasodilatory and analgesic drugs)
Number of subjects: 34
Study: 36326824

Group type: EXPERIMENTAL
Intervention: High-dose convalescent plasma (CCP)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Higher cumulative amount of neutralizing antibodies (subgroup of CCP)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no CCP)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: CCP
Number of subjects: 105
Study: 35298469

Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (gPM+)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 410
Study: 32178235

Group type: EXPERIMENTAL
Intervention: Cascade-parallel LSTM-CRF
Number of subjects: 5408

Group type: COMPARATOR
Intervention: Traditional machine learning algorithms (multilayer perception, logistic regression, decision tree)
Number of subjects: 5408
Study: 35338353

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 0
Study: 36319597

Group type: EXPERIMENTAL
Intervention: 8-hour time-restricted eating (TRE) (ad libitum 12 PM-8 PM)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Daily calorie restriction (Cal-R) (25% restriction daily)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control
Number of subjects: 255
Study: 32454921

Group type: EXPERIMENTAL
Intervention: Radiofrequency waves (20 J, 3 MHz, 10 minutes duration) applied to the masticatory muscles.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sonophoresis procedures (0.9 W/cm2, 80% duty factor, 10 minutes duration) applied to the masticatory muscles with 25% Voltaren gel.
Number of subjects: 40
Study: 35845740

Group type: EXPERIMENTAL
Intervention: General anesthesia combined with epidural block (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total intravenous anesthesia (Group B)
Number of subjects: 40
Study: 34143668

Group type: EXPERIMENTAL
Intervention: Wii™ (virtual rehabilitation)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (stretching exercises)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups (Wii™ and Control)
Number of subjects: 35
Study: 33791673

Group type: COMPARATOR
Intervention: TransFORM Body Treatment with TriHex Technology (TFB)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Regenerating Skin Nectar with TriHex Technology (RSN) + TransFORM Body Treatment with TriHex Technology (TFB)
Number of subjects: 10
Study: 32360666

Group type: EXPERIMENTAL
Intervention: Progesterone vaginal ring (PVR)
Number of subjects: 789

Group type: COMPARATOR
Intervention: Copper-T380A intrauterine device (IUD)
Number of subjects: 789
Study: 35717995

Group type: EXPERIMENTAL
Intervention: BBV152 (COVAXIN); two 0.5 mL intramuscular doses on days 0 and 28.
Number of subjects: 526
Study: 34183570

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF) with wrap fixation (suturing the wrap to the diaphragmatic crura or to the body of stomach)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Laparoscopic Nissen fundoplication (LNF) without wrap fixation
Number of subjects: 102
Study: 33207158

Group type: EXPERIMENTAL
Intervention: Hospital-based violence intervention programs (HVIPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard emergency department care without HVIP
Number of subjects: 0
Study: 36256502

Group type: EXPERIMENTAL
Intervention: Transcutaneous Neuromodulation (TN)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham TN
Number of subjects: 56
Study: 34038632

Group type: EXPERIMENTAL
Intervention: Immediate kangaroo mother care
Number of subjects: 3211

Group type: COMPARATOR
Intervention: Conventional care (incubator or radiant warmer until stabilization)
Number of subjects: 3211
Study: 32441471

Group type: EXPERIMENTAL
Intervention: Plain Breakfast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sugar-Sweetened Breakfast
Number of subjects: 0
Study: 35379563

Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platinum-based doublet chemotherapy (standard care)
Number of subjects: 0
Study: 33125466

Group type: EXPERIMENTAL
Intervention: Androgyny (high masculinity and high femininity)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Gender roles
Number of subjects: 301
Study: 32928754

Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed
Number of subjects: 11007

Group type: COMPARATOR
Intervention: No antibiotics prescribed
Number of subjects: 11007

Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed for men aged 15 to 24 years
Number of subjects: 11007

Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed for men aged 25 to 34 years
Number of subjects: 11007

Group type: EXPERIMENTAL
Intervention: General risk of PTA following RTI consultation
Number of subjects: 11007
Study: 33543874

Group type: EXPERIMENTAL
Intervention: ICR plus CXL
Number of subjects: 35

Group type: COMPARATOR
Intervention: ICR only
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 32365732

Group type: EXPERIMENTAL
Intervention: capsules with starch-adsorbed VitD (1000 IU; 25 µg daily)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: oil-based Valens VitD oral spray (1000 IU; 25 µg daily)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: water-based Valens VitD oral spray (1000 IU; 25 µg daily)
Number of subjects: 105

Group type: COMPARATOR
Intervention: control group (no supplemental VitD)
Number of subjects: 105
Study: 33413519

Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation
Number of subjects: 199

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 199
Study: 32298717

Group type: EXPERIMENTAL
Intervention: DMAU (dimethandrolone undecanoate)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: DMAU
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: DMAU and Placebo
Number of subjects: 57
Study: 35035867

Group type: COMPARATOR
Intervention: Ultrasound-guided stellate ganglion block
Number of subjects: 36

Group type: COMPARATOR
Intervention: Extracorporeal shock wave therapy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined treatment (Ultrasound-guided stellate ganglion block + Extracorporeal shock wave therapy)
Number of subjects: 36
Study: 32024486

Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise protocol (AEP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Delayed start 6-week placebo-like stretching protocol (SP) followed by AEP
Number of subjects: 56
Study: 34100975

Group type: EXPERIMENTAL
Intervention: Absorbable sutures (Vicryl)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Non-absorbable sutures (Ethibond)
Number of subjects: 195
Study: 32594522

Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg
Number of subjects: 327

Group type: COMPARATOR
Intervention: Secukinumab 300 mg
Number of subjects: 327
Study: 34890104

Group type: EXPERIMENTAL
Intervention: iCanQuit (ACT-based smartphone application)
Number of subjects: 554

Group type: COMPARATOR
Intervention: QuitGuide (USCPG-based smartphone application)
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: iCanQuit
Number of subjects: 554

Group type: COMPARATOR
Intervention: QuitGuide
Number of subjects: 554
Study: 32003150

Group type: EXPERIMENTAL
Intervention: DAPA + SAXA
Number of subjects: 1163

Group type: COMPARATOR
Intervention: INS
Number of subjects: 1163
Study: 35830132

Group type: EXPERIMENTAL
Intervention: Application of ascorbic acid (two days after irrigation treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application of mycorrhiza fungus with Azospirillium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-consumption of biological fertilizers
Number of subjects: 0
Study: 33591346

Group type: EXPERIMENTAL
Intervention: High-Intensity Strength Training
Number of subjects: 377

Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Low-Intensity Strength Training
Number of subjects: 377
Study: 33570647

Group type: EXPERIMENTAL
Intervention: Prophylaxis for frequent recurrent bleeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desmopressin trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiplatelet agents and anticoagulant therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Target VWF and factor VIII activity levels for major surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strategies to reduce bleeding during minor surgery or invasive procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Management options for heavy menstrual bleeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Management of VWD in the context of neuraxial anesthesia during labor and delivery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Management in the postpartum setting
Number of subjects: 0
Study: 36436541

Group type: EXPERIMENTAL
Intervention: Video laryngoscopy with supplemental oxygen (1 L/Kg per min)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Direct laryngoscopy with supplemental oxygen (1 L/Kg per min)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Both groups (Video laryngoscopy and Direct laryngoscopy)
Number of subjects: 250
Study: 33955229

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure treatment (<120 mm Hg)
Number of subjects: 8584

Group type: COMPARATOR
Intervention: Standard treatment (<140 mm Hg)
Number of subjects: 8584
Study: 34304615

Group type: EXPERIMENTAL
Intervention: 19 F bidirectional cannula (Biflow™, LivaNova, Italy)
Number of subjects: 64

Group type: COMPARATOR
Intervention: 19 F conventional cannula (HLS Peripheral cannula, Getinge Group™, Germany)
Number of subjects: 64
Study: 33494753

Group type: EXPERIMENTAL
Intervention: National cancer registration for ovarian/tubal/peritoneal cancer
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: Death registration for tubo-ovarian cancer
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: Multiple electronic health record sources for cancer site
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: Multiple electronic health record sources for cause of death
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: Cancer registration accuracy
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: Death registration accuracy
Number of subjects: 3110
Study: 35763045

Group type: EXPERIMENTAL
Intervention: Treadmill walking at moderate intensity (40-60% of age-adjusted maximal heart rate), three times per week for 12 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Electronic lectures on diet, diabetes, and mental health
Number of subjects: 49
Study: 33000539

Group type: EXPERIMENTAL
Intervention: Fissure sealant therapy
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control (non-sealed teeth)
Number of subjects: 124
Study: 32960955

Group type: EXPERIMENTAL
Intervention: Vacuum bell therapy and physiotherapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Vacuum bell treatment only
Number of subjects: 26
Study: 35501676

Group type: EXPERIMENTAL
Intervention: Regular, one 30 s ARM (RARMs)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Improved and intermittent, three 10s ARMs (IARMs)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control (C), no ARMs
Number of subjects: 252
Study: 32249637

Group type: EXPERIMENTAL
Intervention: Modified anti-inflammatory diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy diet recommendations (Control)
Number of subjects: 100
Study: 32349429

Group type: EXPERIMENTAL
Intervention: Lupin biscuits (20% lupin)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wholemeal spelt biscuits
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard plain sweet biscuits
Number of subjects: 20
Study: 35499204

Group type: EXPERIMENTAL
Intervention: SM-88 Regimen (460 or 920 mg daily with methoxsalen, phenytoin, and sirolimus)
Number of subjects: 49
Study: 34360036

Group type: COMPARATOR
Intervention: Diet control group (D)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Diet control plus elastic band exercise group (D + E)
Number of subjects: 66
Study: 35168531

Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bisoprolol 2.5 mg followed by combination treatment with bisoprolol 5 mg and amlodipine 5 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bisoprolol (2.5 mg - 5 mg - 10 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination treatment with bisoprolol and amlodipine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 33819336

Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue graft from the palate after deepithelialization (DE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft obtained with parallel incision (PI)
Number of subjects: 0
Study: 33894762

Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of inferior facial angle (IFA)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of maxilla-nasion-mandible (MNM) angle
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of facial maxillary angle (FMA)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of profile line (PL) distance
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of IFA
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of MNM angle
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of FMA
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of PL distance
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Correlation of IFA with crown-rump length (CRL)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Correlation of PL distance with crown-rump length (CRL)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Correlation of MNM angle with crown-rump length (CRL)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Correlation of FMA with crown-rump length (CRL)
Number of subjects: 380
Study: 35576345

Group type: EXPERIMENTAL
Intervention: BMI < 25
Number of subjects: 6058

Group type: EXPERIMENTAL
Intervention: BMI 40 or higher
Number of subjects: 6058

Group type: EXPERIMENTAL
Intervention: Every 5-unit increase in BMI
Number of subjects: 6058
Study: 35483994

Group type: EXPERIMENTAL
Intervention: Telemedicine (TM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study: 33954851

Group type: EXPERIMENTAL
Intervention: Group Pain (GP)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Group Strain (GS)
Number of subjects: 64
Study: 32690858

Group type: EXPERIMENTAL
Intervention: Various clinical and pathological factors analyzed using SPSS to predict overall survival (OS)
Number of subjects: 266
Study: 35574874

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diabetes fatalism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diabetes knowledge
Number of subjects: 0
Study: 34280656

Group type: EXPERIMENTAL
Intervention: PICS classification models
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Higher age and longer duration of ICU treatment and mechanical ventilation
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Male gender and higher age
Number of subjects: 289
Study: 36149935

Group type: EXPERIMENTAL
Intervention: miR-1
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: miR-21
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: miR-23
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: miR-423-5-p
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (healthy participants)
Number of subjects: 44
Study: 34156521

Group type: EXPERIMENTAL
Intervention: Polymer-free sirolimus-eluting stent (PF-SES)
Number of subjects: 3002

Group type: COMPARATOR
Intervention: Durable polymer zotarolimus-eluting stent (DP-ZES)
Number of subjects: 3002
Study: 33034360

Group type: EXPERIMENTAL
Intervention: SmartSurfACE transepithelial PRK
Number of subjects: 2

Group type: COMPARATOR
Intervention: Streamlight transepithelial PRK
Number of subjects: 2
Study: 35969440

Group type: EXPERIMENTAL
Intervention: Educational module completion (central intervention component)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Educational module completion
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Total number of meditations
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Use of the stress meter
Number of subjects: 27
Study: 34787258

Group type: EXPERIMENTAL
Intervention: Aspirin plus verapamil (n=26)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n=6)
Number of subjects: 32
Study: 32388647

Group type: EXPERIMENTAL
Intervention: Local anesthetic (LA) injection into the suprascapular notch
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: LA and corticosteroid (CS) injections into the suprascapular notch
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo group (LA injection into the trapezius muscle)
Number of subjects: 34
Study: 35028918

Group type: EXPERIMENTAL
Intervention: Smartphone mirroring-based telepresence exercise program (20-40 min, 3 times a week for 12 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group performing the same exercise program at the senior citizen center
Number of subjects: 29
Study: 33024268

Group type: EXPERIMENTAL
Intervention: FOLFOXIRI ± bev reintroduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doublets ± bev or other treatments
Number of subjects: 0
Study: 34981666

Group type: EXPERIMENTAL
Intervention: 5-mg amlodipine besylate tablets (generic formulation) in fasting trial
Number of subjects: 56

Group type: COMPARATOR
Intervention: 5-mg amlodipine besylate tablets (original formulation) in postprandial trial
Number of subjects: 56

Group type: COMPARATOR
Intervention: Fasting condition
Number of subjects: 56

Group type: COMPARATOR
Intervention: Postprandial condition
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Safety assessment throughout the study
Number of subjects: 56
Study: 33485731

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 32069857

Group type: EXPERIMENTAL
Intervention: High-carbohydrate morning-intake (HCM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-carbohydrate morning-intake (LCM)
Number of subjects: 12
Study: 35144698

Group type: EXPERIMENTAL
Intervention: HM plus HM lyophilisate (LioNeo)
Number of subjects: 40

Group type: COMPARATOR
Intervention: HM plus commercial additive (HMCA)
Number of subjects: 40
Study: 36419133

Group type: EXPERIMENTAL
Intervention: Finger feeding
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Cup feeding
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Syringe feeding
Number of subjects: 99
Study: 32618279

Group type: EXPERIMENTAL
Intervention: ZPIV vaccine (5 μg) via standard regimen (weeks 0 and 4)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ZPIV vaccine (5 μg) via accelerated regimen (weeks 0 and 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ZPIV vaccine (5 μg) via single-dose regimen (week 0)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 36
Study: 35953563

Group type: EXPERIMENTAL
Intervention: Incentivized Adherence and Abstinence monitoring (I‐AAM)
Number of subjects: 141

Group type: COMPARATOR
Intervention: treatment‐as‐usual (control)
Number of subjects: 141
Study: 33602468

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22